Training substance abuse treatment staff to care for co-occurring disorders

References 

1. Andrews FM, Withey SB. Social indicators of well-being: Americans' perceptions of life quality. New York: Plenum; 1976;
2. American Association of Community Psychiatrists. Principles for the care and treatment of persons with co-occurring psychiatric and substance disorders. Website of the American Association of Community Psychiatrists. “Findings”. 2000;http://www.comm.psych.pitt.edu/finds/dualdx.html
3. Bandura A. Human agency in social cognitive theory. American Psychologist. 1989;44:1175–1184
4. Bandura A. Self-efficacy: The exercise of control. New York: Freeman; 1997;
5. Bero LA, Grilli R, Grimshaw JM, Harvey E, Oxman AD, Thompson MA on behalf of the Cochrane Effective Practice and Organization of Care Review Group. (Getting research findings into practice) Closing the gap between research and practice: An overview of systemic reviews of interventions to promote the implementation of research findings. British Medical Journal. 1998;317:465–468
6. Brown RA, Monti PM, Myers MG, Martin RA, Rivinus T, Dubreuil ME, et al. Depression among cocaine abusers in treatment: Relation to cocaine and alcohol use and treatment outcome. American Journal of Psychiatry. 1998;144:220–225
7. Campbell A, Converse PE, Rodgers WL. The quality of American life: Perceptions, evaluations, and satisfactions. New York: Russell Sage Foundation; 1976;
8. Carroll KM, Power ME, Bryant K, Rounsaville BJ. One-year follow-up status of treatment-seeking cocaine abusers: Psychopathology and dependence severity as predictors of outcome. Journal of Nervous and Mental Disease. 1993;181:71–79
9. Center for Mental Health Services (CMHS), Substance Abuse and Mental Health Services Administration . National dialogue on co-occurring mental health and substance abuse disorders. Rockville, MD: Center for Mental Health Services; 1999;
10. Center for Substance Abuse Treatment . Substance abuse treatment for persons with co-occurring disorders. Treatment Improvement Protocol (TIP) series. Rockville, MD: U.S. Department of Health and Human Services; 2002;
11. Cohen J, Struening EL. Opinions about mental illness in the personnel of two large mental hospitals. Journal of Abnormal and Social Psychology. 1962;64:349–360
    • MEDLINE
    • CrossRef
12. Daley DC. Dual Diagnosis Workbook. Independence, MO: Herald House/Independent Press; 1994;
13. Daley DC, Thase ME. Dual disorders recovery counseling. Independence, MO: Herald House/Independent Press; 1994;
14. D'Aunno TA. Linking substance abuse treatment and primary healthcare. In:  Edgertson JA,  Fox DM,  Leshner AL editor. Treating drug users effectively. Malden, MA: Blackwell; 1997;p. 311–351
15. Davis DA, Thomson MA, Oxman AD, Haynes RB. Changing physician performance: A systematic review of the effect of continuing medical education strategies. Journal of the American Medical Association. 1995;274:700–705
16. Donabedian A. Methods for deriving criteria for assessing the quality of medical care. Medical Care Review. 1980;37:653–698
    • MEDLINE
17. Drake RE, Mercer-McFadden C, Mueser KT, McHugo GJ, Bond GR. A review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophrenia Bulletin. 1998;24:589–608
    • MEDLINE
    • CrossRef
18. Friedmann PD, Alexander JA, Jin L, D'Aunno TA. On-site primary care and mental health services in outpatient drug abuse treatment units. Journal of Behavioral Health Services & Research. 1999;26:80
19. Garnick DW, Hendrics AW, Drainnoni M. Private sector coverage of people with dual diagnoses. Journal of Mental Health Administration. 1996;23:317–328
    • MEDLINE
    • CrossRef
20. Grella CE, Hser Y-I. A county survey of mental health services in drug treatment programs. Psychiatric Services. 1997;48:950–952
21. Hien D, Zimberg S, Weisman S, First M, Ackerman S. Dual diagnosis subtypes in urban substance abuse and mental health clinics. Psychiatric Services. 1997;48:1058–1063
22. Hoff RA, Rosenheck RA. The cost of treating substance abuse patients with and without comorbid psychiatric disorders. Psychiatric Services. 1999;50:1309–1315
23. Hser, Y. I. (1996). UCLA DARC/RAND DPRC Drug Treatment Process Project [Counselor interview]. Unpublished protocol, University of California, Los Angeles.
24. Katon W, VonKorff M, Lin E, Simon G, Walker E, Unützer J, et al. Stepped collaborative care for primary care patients with persistent symptoms of depression: A randomized trial. Archives of General Psychiatry. 1999;56:1109–1115
    • MEDLINE
    • CrossRef
25. Kessler RC, Nelson CB, McGonagle KA, Liu J, Swartz M, Blazer DG. Comorbidity of DSM-III-R major depressive disorder in the general population: Results from the US National Comorbidity Survey. British Journal of Psychiatry Supplement. 1996;17–30
26. Larkin TJ, Larkin S. Communicating change: How to win employee support for new business directions. New York: McGraw-Hill; 1994;
27. Maslach C, Jackson SE. Maslach Burnout Inventory—Human Services Survey (MBI-HSS). In:  Maslach C,  Jackson SE,  Leiter MP editor. MBI manual. 3rd ed.. Palo Alto, CA: Consulting Psychologists Press; 1996;p. 5
28. McGlynn EA, Norquist GS, Wells KB, Sullivan G, Liberman RP. Quality of care research in mental health: Responding to the challenge. Inquiry. 1988;25:157–170
    • MEDLINE
29. McLellan AT, Luborsky L, Woody GE, O'Brien CP, Druley KA. Predicting response to alcohol and drug abuse treatments: Role of psychiatric severity. Archives of General Psychiatry. 1983;40:620–625
    • MEDLINE
30. Mendel, P., Ridgely, M. S., & Koegel, P. (2002). Where do homeless adults with alcohol and other drug disorders receive treatment? Descriptive findings from a comprehensive cross-sector survey of programs in Houston. Santa Monica, CA: RAND.
31. Morrissey, J. (2000). Survey of mental health and substance abuse service agencies, Version 10_27. Unpublished protocol, University of North Carolina.
32. Mueser KT, Drake RE, Miles KM. The course and treatment of substance use disorder in persons with severe mental illness. In:  Onken LS,  Blaine JD,  Genser S,  Horton AM editor. Treatment of drug-dependent individuals with comorbid mental disorders. Rockville, MD: U.S. Department of Health and Human Services; 1997;p. 86–109
33. Muñoz RF, Ippen CG, Rao S, Le H-N, Dwyer EV. Manual for group cognitive–behavioral therapy of major depression. San Francisco: University of California, San Francisco; 2000;
34. Oxman AD, Thomson MA, Davis DA, Haynes RB. No magic bullets: A systematic review of 102 trials of interventions to improve professional practice. Canadian Medical Association Journal. 1995;153:1423–1431
35. Ridgely MS, Goldman HH, Willenbring M. Barriers to the care of persons with dual diagnoses: Organizational and financing issues. Schizophrenia Bulletin. 1990;116:123–132
36. Ross HE, Glaser FB, Germanson T. The prevalence of psychiatric disorders in patients with alcohol and other drug problems. Archives of General Psychiatry. 1988;45:1023–1031
    • MEDLINE
37. Rounsaville BJ, Dolinsky ZS, Babor TF, Meyer RE. Psychopathology as a predictor of treatment outcome in alcoholics. Archives of General Psychiatry. 1987;44:505–513
    • MEDLINE
38. Rounsaville BJ, Koste T, Weissman N, Kleber H. Prognostic significance of psychopathology in treated opiate addicts. Archives of General Psychiatry. 1986;43:739–745
    • MEDLINE
39. Samet JH, Saitz R, Larson MJ. A case for enhanced linkage of substance abusers to primary medical care. Substance Abuse. 1996;17:181–199
40. Schoenbaum M, Unützer J, McCaffrey D, Duan N, Sherbourne CD, Wells KB. The effects of primary care depression treatment on patients' clinical status and employment. Health Services Research. 2000;37:1125–1127
    • MEDLINE
    • CrossRef
41. Sciacca K, Thompson CM. Program development and integrated treatment across systems for dual diagnosis: Mental illness, drug addiction, and alcoholism (MIDAA). Journal of Mental Health Administration. 1996;23:288–297
    • MEDLINE
    • CrossRef
42. In:  Solomon J,  Zimberg S,  Shollar E editor. Dual diagnosis: Evaluation, treatment, training, and program development. New York: Plenum; 1993;
43. U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration. (2002). Co-occurring substance abuse and mental disorders. Report to U.S. Congress.
44. U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration . SAMHSA Drug and Alcohol Services Information System Series: S-7, Treatment Episode Data Set (TEDS): 1992–1997. Rockville, MD: National Admissions to Substance Abuse Treatment Services, Office of Applied Studies; 1999;
45. Watkins K. Health wellness and recovery. Santa Monica, CA: RAND; 2003;(Copyright pending)
46. Watkins K, Burnam A, Kung F-Y, Paddock S. A national survey of care for persons with co-occurring mental and substance use disorders. Psychiatric Services. 2001;52:1062–1068
47. Wells KB. Treatment research at the crossroads: The scientific interface of clinical trials and effectiveness research. American Journal of Psychiatry. 1999;156:5–10
48. Wells KB, Sherbourne C, Schoenbaum M, Duan N, Meredith LS, Unützer J, et al. Impact of disseminating quality improvement programs for depression in managed primary care: A randomized controlled trial. Journal of the American Medical Association. 2000;283:212–220
49. Wenzel S, Turner S, Ridgely MS. Collaborative linkages: Drug courts and service providers. RAND PM-1372-NIDA Santa Monica, CA: RAND; 2002;
50. Westermeyer J, Eames SL, Nugent S. Comorbid dysthymia and substance disorder: Treatment history and cost. American Journal of Psychiatry. 1998;155:1556–1560
51. Wu L-T, Ringwalt CL, Williams CE. Use of substance abuse treatment services by persons with mental health and substance use problems. Psychiatric Services. 2003;54:363–369
52. Young NK, Grella CE. Mental health and substance abuse treatment services for dually diagnosed clients: Results of a statewide survey of county administrators. Journal of Behavioral Health Services & Research. 1998;25:83–92